Risk alert: Birth control pills recalled

May 30, 2018 Laura Hale Brockway

Almost 170,000 sample packs of Taytulla birth control pills are being recalled because placebo and active capsules were packaged out of order, increasing the risk of unwanted pregnancy. The sample packs were distributed to physicians across the US.

According to the FDA recall notice, Allergan recently identified — through a physician report —  that four placebo capsules were placed out of order in a sample pack of Taytulla. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules.

The affected lot numbers and photos of the product are available from the FDA recall notice. Allergan is notifying customers by recall letter and advising women who have used a Taytulla sample pack from the recalled lot to consult with their physician.

Health care professionals are encouraged to report adverse events or side effects to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

About the Author

Laura Hale Brockway is the Assistant Vice President of Marketing at TMLT. She can be reached at laura-brockway@tmlt.org.

Visit Website More Content by Laura Hale Brockway
Previous Presentation
Addressing transgender health care disparities
Addressing transgender health care disparities

A discussion of transgender health care disparities and how practicing cultural competency can improve pati...

Next Presentation
Top 10 risk management recommendations
Top 10 risk management recommendations

TMLT staff conduct on-site reviews to help physicians address their medical liability risks. Here are our m...